Pathology News
admin

About admin@pathologynews.com

This author has not yet filled in any details.
So far admin@pathologynews.com has created 1089 blog entries.

March 2024

Conversation with Daniel Plews, Product Manager for Digital Pathology at Roche Diagnostics UK & Ireland

2025-06-27T10:25:39+00:00

Daniel Plews, Product Manager for Digital Pathology at Roche Diagnostics UK & Ireland, discusses the evolution of digital pathology, emphasizing advancements in scanning technology, partnerships for enhancing digital offerings, the potential of AI in diagnostics, the future of pathology labs transitioning towards digital methodologies, and the strategic importance of data storage and utilization, during an interview with Jonathon Tunstall for Pathology News.

Conversation with Daniel Plews, Product Manager for Digital Pathology at Roche Diagnostics UK & Ireland2025-06-27T10:25:39+00:00

Double The Number Of Patients At Half The Cost: Digital Innovation In Mohs Surgery

2024-03-15T10:36:03+00:00

The worldwide increase in cancer, predicted by the International Agency for Research on Cancer (IARC), requires the urgent optimisation and digitalisation of current treatment processes. A pioneering study led by Prof. Dr Jan Gutermuth at the University Hospital of Brussels presents a revolutionary approach: the integration of Ex Vivo Confocal Microscopy (EVCM) during Mohs Micrographic Surgery (MMS) for Basal Cell Carcinoma (BCC) using the VivaScope 2500, which has been proven to enable a more precise and faster assessment of tumour extension and resection margins, leading to a significant increase in efficiency. Prof Dr Jan Gutermuth and his team have proven that the waiting time for patients has been reduced, costs have been more than halved and the quality of patient care has been improved. The results have far-reaching implications for the healthcare system by enabling more effective and cost-efficient treatment of skin cancer.

Double The Number Of Patients At Half The Cost: Digital Innovation In Mohs Surgery2024-03-15T10:36:03+00:00

Aiosyn And Physiogenex Partner To Enhance Kidney Disease Drug Development

2024-03-14T14:06:04+00:00

Aiosyn, a pioneering medical software company specializing in AI-powered pathology solutions for cancer and kidney disease, has announced a collaboration with Physiogenex, a leading preclinical Contract Research Organization (CRO) specializing in metabolic diseases.

Aiosyn And Physiogenex Partner To Enhance Kidney Disease Drug Development2024-03-14T14:06:04+00:00

Philips and AWS Collaborate To Scale Digital Pathology In The Cloud, Enhancing Diagnostic Capabilities and Improving Productivity

2024-03-14T10:42:57+00:00

Philips and AWS will advance digital pathology and help pathology labs to efficiently store, manage, and analyze growing volumes of digital pathology data and enable more pathology labs to adopt digital workflows to increase productivity. In addition, pathology labs will be able to optimize workflow efficiency and facilitate collaboration among specialists, enabling seamless integration with existing healthcare systems to deliver holistic patient care.

Philips and AWS Collaborate To Scale Digital Pathology In The Cloud, Enhancing Diagnostic Capabilities and Improving Productivity2024-03-14T10:42:57+00:00

Cerba Research Case Study: Evidence For The Utility Of AI In Ki-67 Quantification In Solid Tumors

2024-03-13T10:50:38+00:00

Although it is an important biomarker in oncology (mostly in breast and prostate), Ki-67 immunohistochemistry (IHC) analysis has yet to be standardized. Working groups have provided guidelines for Ki-67 scoring in different cancer types to limit pathologist’s variability.¹‚² AI solutions to assist scoring have recently emerged in the evaluation of Ki-67 as rapid and robust solutions. In this study, we compared the results of Ki-67 scoring performed with Aiforia® Platform (deep learning AI platform) against three independent pathologists on various solid tumors.

Cerba Research Case Study: Evidence For The Utility Of AI In Ki-67 Quantification In Solid Tumors2024-03-13T10:50:38+00:00

Aiforia releases Aiforia® Studies, a pioneering GLP-compliant AI-assisted image analysis workflow for non-clinical histology studies

2024-03-06T15:05:05+00:00

Aiforia Technologies Plc announces the release of Aiforia® Studies, a software module that offers AI-assisted image analysis workflow within the framework of Good Laboratory Practices (GLP).

Aiforia releases Aiforia® Studies, a pioneering GLP-compliant AI-assisted image analysis workflow for non-clinical histology studies2024-03-06T15:05:05+00:00

Aiosyn Launches Kidney Image Analysis Services Through Its NephroPath Platform To Accelerate Drug Development Studies

2024-03-01T08:06:29+00:00

Aiosyn, a pioneering medical software company specializing in AI-powered pathology solutions for cancer and kidney disease, announced the introduction of its NephroPath platform. By partnering with Aiosyn, CROs, biopharma, and researchers can accelerate the development of Chronic Kidney Disease (CKD) therapies using new and quantitative insights offered through Nephropath’s Kidney Image Analysis Services.

Aiosyn Launches Kidney Image Analysis Services Through Its NephroPath Platform To Accelerate Drug Development Studies2024-03-01T08:06:29+00:00
Go to Top